XNAS
CRAI
Market cap1.01bUSD
Jul 10, Last price
160.64USD
1D
1.61%
1Q
-2.39%
Jan 2017
327.30%
Name
CRA International Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CRA International, Inc., along with its affiliated entities, delivers specialized advisory services across the domains of economics, finance, and management in the United States, the United Kingdom, and globally. The firm provides expert guidance to clients on economic and financial considerations arising from legal disputes and regulatory challenges. Additionally, it collaborates with corporations to address matters of business strategy and operational effectiveness. Its comprehensive consulting offerings encompass in-depth research and analysis, expert witness testimony, and robust support for corporate clients and legal practitioners navigating litigation and regulatory proceedings. These services cover critical areas such as finance, accounting, economics, insurance, and forensic accounting and investigations. Moreover, CRA International's management consulting capabilities are extensive, covering areas like strategy formulation, performance enhancement, corporate strategic planning, portfolio analysis, market demand forecasting, new product pricing strategies, valuation of intellectual property and other assets, competitive intelligence, and the evaluation of new supply chain opportunities. The company's clientele spans numerous industries, including communications and media; consumer, health, and wellness products; energy; entertainment and leisure; financial services; healthcare; life sciences; manufacturing; natural resources; retail and distribution; technology; and transportation. Established in 1965, CRA International, Inc. is headquartered in Boston, Massachusetts.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑00 | 2024‑12 | 2023‑12 | 2023‑12 | 2022‑12 | 2022‑00 | 2021‑12 | 2021‑00 | 2020‑12 | 2019‑12 | 2019‑12 | 2018‑12 | 2018‑12 | 2017‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||||||
Revenues | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Unusual Expense (Income) | ||||||||||||||||
NOPBT | ||||||||||||||||
NOPBT Margin | ||||||||||||||||
Operating Taxes | ||||||||||||||||
Tax Rate | ||||||||||||||||
NOPAT | ||||||||||||||||
Net income | ||||||||||||||||
Dividends | ||||||||||||||||
Dividend yield | ||||||||||||||||
Proceeds from repurchase of equity | ||||||||||||||||
BB yield | ||||||||||||||||
| Debt | ||||||||||||||||
Debt current | ||||||||||||||||
Long-term debt | ||||||||||||||||
Deferred revenue | ||||||||||||||||
Other long-term liabilities | ||||||||||||||||
Net debt | ||||||||||||||||
| Cash flow | ||||||||||||||||
Cash from operating activities | ||||||||||||||||
CAPEX | ||||||||||||||||
Cash from investing activities | ||||||||||||||||
Cash from financing activities | ||||||||||||||||
FCF | ||||||||||||||||
| Balance | ||||||||||||||||
Cash | ||||||||||||||||
Long term investments | ||||||||||||||||
Excess cash | ||||||||||||||||
Stockholders' equity | ||||||||||||||||
Invested Capital | ||||||||||||||||
ROIC | ||||||||||||||||
ROCE | ||||||||||||||||
| EV | ||||||||||||||||
Common stock shares outstanding | ||||||||||||||||
Price | ||||||||||||||||
Market cap | ||||||||||||||||
EV | ||||||||||||||||
EBITDA | ||||||||||||||||
EV/EBITDA | ||||||||||||||||
Interest | ||||||||||||||||
Interest/NOPBT | ||||||||||||||||